Qadeer, Zulekha A.
Valle-Garcia, David
Hasson, Dan
Sun, Zhen
Cook, April
Nguyen, Christie
Soriano, Aroa
Ma, Anqi
Griffiths, Lyra M.
Zeineldin, Maged
Filipescu, Dan
Jubierre, Luz
Chowdhury, Asif
Deevy, Orla
Chen, Xiang
Finkelstein, David B.
Bahrami, Armita
Stewart, Elizabeth
Federico, Sara
Gallego, Soledad
Dekio, Fumiko
Fowkes, Mary
Meni, David
Maris, John M.
Weiss, William A.
Roberts, Stephen S.
Cheung, Nai-Kong V.
Jin, Jian
Segura, Miguel F.
Dyer, Michael A.
Bernstein, Emily
Funding for this research was provided by:
National Cancer Institute (T32CA078207-11)
Alex's Lemonade Stand Foundation for Childhood Cancer
Passano Foundation
Sixth Framework Programme (R01 CA124709)
Sixth Framework Programme (R01 GM122749)
U.S. Department of Defense (CA150773)
U.S. Department of Defense (T32CA151022-07)
European Regional Development Fund
Howard Hughes Medical Institute
American Lebanese Syrian Associated Charities
National Science Foundation (ACI-1445606)
National Science Foundation (ACI-1548562)
Instituto de Salud Carlos III (CPII16/00006)
Instituto de Salud Carlos III (PI14/00561)
National Institutes of Health
St. Baldrick's Foundation
Icahn School of Medicine at Mount Sinai (S10OD018522)
St. Jude Children's Research Hospital (CA168875)
St. Jude Children's Research Hospital (EY014867)
St. Jude Children's Research Hospital (EY018599)
This article is maintained by: Elsevier
Article Title: ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures
Journal Title: Cancer Cell
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ccell.2019.09.002
Content Type: article
Copyright: © 2019 Elsevier Inc.